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Mutations of CIAS1 have recently been shown to underlie familial cold urticaria (FCU) andMuckle-Wells syndrome
(MWS), in three families and one family, respectively. These rare autosomal dominant diseases are both characterized
by recurrent inflammatory crises that start in childhood and that are generally associated with fever, arthralgia,
and urticaria. The presence of sensorineural deafness that occurs later in life is characteristic of MWS. Amyloidosis
of the amyloidosis-associated type is the main complication of MWS and is sometimes associated with FCU. In
FCU, cold exposure is the triggering factor of the inflammatory crisis. We identified CIAS1 mutations, all located
in exon 3, in nine unrelated families with MWS and in three unrelated families with FCU, originating from France,
England, and Algeria. Five mutations—namely, R260W, D303N, T348M, A439T, and G569R—were novel. The
R260W mutation was identified in two families with MWS and in two families with FCU, of different ethnic
origins, thereby demonstrating that a single CIAS1 mutation may cause both syndromes. This result indicates that
modifier genes are involved in determining either a MWS or a FCU phenotype. The finding of the G569R mutation
in an asymptomatic individual further emphasizes the importance of such modifier a gene (or genes) in determining
the disease phenotype. Identification of this gene (or these genes) is likely to have significant therapeutic implications
for these severe diseases.
Introduction
Muckle-Wells syndrome (MWS [MIM 191900]) and fa-
milial cold urticaria (FCU [MIM 120100]) belong to the
group of hereditary fever syndromes that includes fa-
milial Mediterranean fever (FMF [MIM 249100]), hy-
perimmunoglobulinemia D with periodic fever syn-
drome (HIDS [MIM 260920]), and tumor necrosis
factor receptor 1–associated periodic syndrome (TRAPS
[MIM 142680 and MIM 134610]) (Delpech and Gra-
teau 2001; Drenth and Van der Meer 2001). MWS and
FCU are rare autosomal dominant disorders reported
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in the northern-European population. The first clinical
signs occur during childhood and generally include fever,
joint inflammation, myalgias, urticaria, and conjuncti-
vitis (Kile and Rusk 1940; Muckle and Wells 1962). In
MWS, a progressive sensorineural deafness occurs later
in life, and a renal amyloidosis of the amyloidosis as-
sociated (AA) type can sometimes be observed (Messier
et al. 1988). In contrast, FCU is defined by a highly
specific clinical feature: the effect of cold on the skin,
which triggers the general symptoms of inflammatory
crises (Hoffman et al. 2001b). MWS and FCU have both
been localized to chromosomal region 1q44 (Cuisset et
al. 1999; Hoffman et al. 2000). Recently, Hoffman et
al. (2001a) identified missense mutations in the CIAS1
gene, which cosegregated in three families with FCU and
in one family with MWS. The gene is expressed in pe-
ripheral blood leukocytes and encodes a protein called
“cryopyrin,” which contains several distinct motifs, in-
cluding a pyrin domain (also found in the marenostrin/
Dode´ et al.: Mutations of CIAS1 Responsible for MWS and FCU 1499
Table 1
List of Families Affected with MWS or FCU
Family Syndrome Nationality Reference
1 MWS French Lagrue et al. 1972
2 MWS French Prost et al. 1976; Barrie`re
et al. 1977
3 FCU French Present study
4 FCU Algerian Present study
5 MWS English Watts et al. 1994
6 MWS French Hedon et al. 1983
7 MWS French Present study
8 MWS French Present study
9 MWS French Present study
10 MWS English Present study
11 MWS French Present study
12 FCU French Bader-Meunier et al. 1996
Table 2
CIAS1 Mutations Found in Families with MWS and FCU
Family
Nucleotide
Change
Amino
Acid
Change
Enzyme-
Site
Change
Control
Frequency
1–4 C778T R260W TaqI()a 0/134
5–8 C1043T T348M NlaIII() 0/146
9 G907A D303N TaqI() 0/138
10 G1705C G569R AciI() 0/122
11 G1315A A439T AciI() 0/122
12 G562A V198M …b …b
a PCR was performed using modified oligonucleotides (see “Pa-
tients, Material, and Methods” section).
b See Hoffmann et al. (2001a).
pyrin encoded by the MEFV gene involved in FMF [Ma-
sumoto et al. 2001]), a central nucleotide-binding site
(NACHT subfamily; for explanation of the “NACHT”
acronym, see the “Discussion” section) domain in exon
3, and a C-terminal domain containing seven leucin-rich
repeats (LRR). Recently, it has been demonstrated that
cryopyrin selectively interacts with apoptosis-associated
specklike protein containing a CARD domain (ASC) and
that ASC linked to cryopyrin activates nuclear factor kB
(NF-kB) (Manji et al. 2002).
In this article, we present five new mutations, all lo-
cated in exon 3 of CIAS1, in 12 families with MWS or
FCU. Of these 12 families with MWS, 3 were previously
studied for the localization of MWS to the 1q44 chro-
mosomal region (Cuisset et al. 1999).
Patients, Material, and Methods
Patients
Mutations in the CIAS1 gene were searched in 12
unrelated families with MWS or FCU (table 1). Pedigrees
are shown in figure 1. Each participant was examined
and provided informed written consent. Studies of some
members of these families have been published else-
where. Patients presented characteristic clinical signs,
such as urticaria, arthralgia, arthritis, fever, ocular signs,
and AA amyloidosis. The presence of sensorineural deaf-
ness allowed us to ascertain MWS and to exclude FCU
(Muckle 1979), whereas the triggering effect of cold was
characteristic of FCU.
Mutation Detection
Peripheral blood was obtained from patients, and
DNA was extracted as described elsewhere (Cuisset et
al. 1999). A mutation search was performed on geno-
mic DNA after PCR amplification of the nine exons of
the CIAS1 gene, through use of oligonucleotides and
experimental conditions described by Hoffman et al.
(2001a). Free nucleotides and oligonucleotides were
eliminated by exonuclease I (10 units) (USB) and shrimp
alkaline phosphatase (1 unit) (USB) treatment at 37C
for 15 min, followed by incubation at 80C for 15 min.
Mutation detection was performed by fluorescent se-
quencing with dye-terminator chemistry (Perkin Elmer)
on a 3100 automated sequencer (ABI Perkin Elmer).
The R260W mutation was analyzed in the control
population by PCR amplification of genomic DNA,
through use of the forward primer MWS-R260W-5′ (5′-
GACCCCGATGATGAGCATTCT-3′) and the reverse
modified primer MWS-R260W-3′ (5′-TCTCACAAGG-
CTCACCTCTC-3′). The PCR products were digested
with the restriction enzyme TaqI, which revealed the
presence of the R260W mutation. The other novel mu-
tations (T348M, D303N, G569R, and A439T) either
abolished or created a restriction site (table 2). This was
used to test the frequency in control population.
Microsatellite Analysis
Genotyping of the CIAS1 gene chromosomal region
was performed with the following eight markers:
AFMB358wg1, D1S423, AFMA274zc5, AFMB005wh9,
D1S2836, D1S2215, AFM142wx1, and D1S2682. We
performed PCR and automated fluorescent genotyping
using standard procedures, as described elsewhere (Cuis-
set et al. 1999).
Single-Nucleotide Polymorphism (SNP) Analysis
The analysis of the sequences allowed us to identify
four SNPs located in exon 3 of the CIAS1 gene. These
SNPs are localized on the third base of codons 219 (C/
T), 242 (A/G), 260 (A/G), and 434 (C/T), and they do
not modify the encoded amino acid. The frequency of
each allele in the control population is given in table 3.
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Figure 1 Pedigree of the 12 families with MWS or FCU, with mutation analysis of CIAS1. Affected individuals are shown as blackened
circles (females) or blackened squares (males). Deceased individuals are denoted by diagonal slashes. A gray circle represents an asymptomatic
individual carrying an MWS mutation.
Table 3
CIAS1 SNPs Identified in the Present Study
Nucleotide
Change Codon
% (No.) of Alleles in the
Unaffected Population
C/T 219 92.5 (37) C, 7.5 (3) T
A/G 242 45 (18) A, 55 (22) G
A/G 260 10 (4) A, 90 (36) G
C/T 434 5 (2) C, 95 (36) T
Results
CIAS1 Mutation Analysis
A total of 12 families, including 9 with MWS and 3
with FCU, were studied (table 1). The nine unrelated
families with MWS include three families previously re-
ported to show linkage to the 1q44 region (Cuisset et
al. 1999), as well as four French and two English families
with a high suspicion of MWS. The three families with
FCU included one Algerian and two French families.
Genealogical trees are shown in figure 1. The main clin-
ical signs of patients are summarized in table 4. Among
these families, we identified a total of six mutations, all
located in exon 3 of the CIAS1 gene; five of these are
novel mutations and were not present in the control
population (table 2). The R260W and T348M mutations
are the main ones encountered in families 1–4 and in
families 5–8, respectively (fig. 2). This R260W mutation
was found in two families with MWS and in two families
with FCU. In families 1–3, the disease segregated over
four generations. Study of families 1, 2, and 5 had pre-
viously allowed us to localize MWS to the 1q44 chro-
mosomal region (Cuisset et al. 1999). Patients in these
families exhibited clinical features of the syndrome. AA
amyloidosis was diagnosed by renal biopsy in family 1
(Messier et al. 1988). In families 3, 4, and 12, the pa-
tients had FCU with urticaria, arthralgia, and fever, since
infancy. The inflammatory crisis in patient 11 of family
3 started after cold exposure. The triggering effect of
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Table 4
Main Clinical Signs of Patients with MWS and FCU
Family and
Patient (Sex) Mutation
Age
(years)
Age at
Onseta
(years) Urticaria Deafness
Articular
Signs
Ocular
Signs Fever Proteinuria
Renal AA
Amyloidosis
1:
5 (F) R260W ? ?       
11 (F) R260W 42 B      ? ?
15 (M) R260W 14 3      ? ?
2:
2 (F) R260W 84 ?      ? ?
4 (M) R260W 60 I      ? ?
5 (F) R260W 60 I      ? ?
10 (F) R260W 36 10      ? ?
11 (M) R260W 34 I       ?
13 (F) R260W 39 I      ? ?
16 (M) R260W 12 3      ? ?
3:
11 (F) R260W 53 1    ?  ? ?
4:
1 (F) R260W 53 I    ?  ? ?
5:
4 (F) T348M 57 2      ? ?
6 (F) T348M 31 B      ? ?
7 (M) T348M 28 B      ? ?
6:
2 (F) T348M 57 ?    ?  ? ?
3 (M) T348M 30 ?      ? ?
7:
4 (F) T348M 47 ?      ? ?
6 (M) T348M 9 ?      ? ?
8:
5 (M) T348M 41 3      ? ?
9:
3 (M) D303N ? B    ?  ? ?
10:
3 (F) G569R 31 B      ? ?
11:
6 (M) A439T ? ?      ? ?
9 (F) A439T 36 3      ? ?
11 (F) A439T 7 2  ?    ? ?
12:
2 (F) V198M 40 1      ? ?
6 (M) V198M 13 B      ? ?
12 (F) V198M 4 B      ? ?
NOTE.—? p unknown;  p present;  p absent.
a B p at birth; I p in infancy.
cold was not observed in patients from families 4 and
12. Both parents of patient 1 of family 4 were from
Algeria. In these three families, the disease was clearly
dominantly inherited.
Families 5–8 with MWS displayed the same T348M
mutation. In contrast to families with the R260W mu-
tation, families with the T348M mutation are small.
Inheritance of this mutation is found only in a two-
generation family. No renal AA amyloidosis was asso-
ciated with this mutation.
The D303N mutation was found in a single patient,
who presented with all clinical criteria of MWS. Since the
parents of this patient have no mutation, D303N can be
considered to be a de novo mutation in this family.
In family 10, patient 3 is the only one affected by
MWS. His mother, patient 2, shares the same mutation,
but, so far, she has not developed clinical signs of MWS.
The G569R mutation seems to be inherited with a low
penetrance. In family 11, MWS is due to a new mutation,
A439T, through four generations. Another mutation at
the same codon, A439V, has been characterized previ-
ously in a family with FCU, which suggests the presence
of a mutational hotspot in this region (Hoffman et al.
2001a). Patients from family 12 had FCU and carried
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Figure 2 DNA-sequence electrophoregrams for the five novel CIAS1 mutations identified in the present study. Upper electrophoregrams
correspond to the patients, lower ones to the control. Arrows indicate the position of the mutation. Sequences showing mutations R260W and
A439T are on the coding strand, and D303N, T348M, and G569R are on the opposite strand.
Figure 3 Physical map of the region surrounding the CIAS1 gene, between microsatellite markers AFMB358wg1 and D1S2682 (UCSC
Human Genome Project Working Draft).
the V198M mutation, which was previously described
in a family with FCU (Hoffman et al. 2001a).
Haplotype Analysis
Do unrelated patients with the same R260W or
T348M mutation share common haplotypes? Sequenc-
ing of the CIAS1 gene in patients with MWS or FCU
allowed us to characterize several SNPs (table 3). We
evaluated the frequency of these SNPs in the control
population. We then used these intragenic SNPs and mi-
crosatellites to construct haplotypes in families 1–8. We
did not find a common founder microsatellite haplotype
for the R260W or T348M mutations, which suggests
that these mutations appear on different alleles (fig. 3
and table 5).
Discussion
The role of CIAS1 in MWS and FCU was originally
discerned on the basis of different missense mutations
found in three families with FCU and in only one family
with MWS (Hoffmann et al. 2001a). The present study
presents the largest series of families and novel mutations
reported since the discovery of the CIAS1 gene and con-
firms its involvement in MWS and FCU. This is the first
demonstration that MWS and FCU can be due to the
Table 5
Genotypes and Haplotypes of Patients with MWS and FCU Carrying the R260W and T348M Mutations
FAMILY
AND PATIENT
GENOTYPE
AFMB358wg1 D1S423 AFM274zc5 AFMB005wh9 D1S2836 D1S2215 T219T (C/G) A242A (A/G) R260W R260R (A/G) T348M S434S (C/T) AFM142xe1 D1S2682
1:
5 2/2 1/2 3/5 2/2 1/4 1/2 C/C A/G R260W G/G … C/T 3/3 4/9
11 2/3 1/1 3/7 2/2 1/1 2/3 C/C G/G R260W G/G … C/C 3/3 4/4
15 2/2 1/2 3/4 2/2 1/1 2/3 C/C A/G R260W G/G … … 2/3 1/4
Haplotype 2 1 3 2 1 2 C G R260W G … C 3 4
2:
2 1/2 2/2 1/5 1/2 2/3 2/3 C/T G/G R260W G/G … … 1/4 1/4
4 1/2 2/2 1/7 1/1 2/6 2/3 C/C A/G R260W G/G … … 1/3 4/4
5 1/2 2/2 1/7 1/1 2/6 2/3 C/C A/G R260W G/G … C/C 1/3 4/4
10 1/2 1/2 1/6 1/2 1/2 2/3 C/C A/G R260W G/G … … 1/1 1/4
11 1/2 1/2 1/6 1/2 1/2 2/3 C/C A/G R260W G/G … C/C 1/1 1/4
13 1/2 2/2 1/8 1/2 1/2 2/3 C/C G/G R260W G/G … … 1/1 2/4
16 1/2 2/2 1/2 1/3 2/4 2/3 C/C G/G R260W G/G … … 1/3 4/4
Haplotype 1 2 1 1 2 2 C G R260W G … C 1 4
5:
4 2/2 1/2 2/3 1/2 1/6 3/? C/C A/A … G/G T348M C/C 3/4 3/4
6 2/3 2/2 1/3 1/2 4/6 3/3 C/C A/A … G/G T348M C/C 1/4 4/4
7 2/2 1/2 2/3 1/2 4/6 3/3 C/C A/A … G/G T348M … 1/4 4/4
Haplotype 2 2 3 1 6 3 C A … G T348M C 4 4
6:
2 2/2 3/5 5/9 1/5 9/10 3/3 … … … … T348M … 3/3 3/4
3 2/2 3/7 9/11 1/2 9/10 3/3 C/C G/G … G/G T348M C/C 3/3 3/3
Haplotype 2 3 9 1 9 3 C G G T348M C 3 3
3:
11 … … … … … … C/C A/G R260W G/G … … … …
4:
1 … … … … … … C/C G/G R260W A/G … C/C … …
7:
6 … … … … … … C/T G/G … G/G T348M C/C … …
8:
5 … … … … … … C/C A/G … A/G T348M C … …
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Figure 4 A, Exon 3 of CIAS1 (GenBank accession number AF427617). The blackened box represents the NACHT domain, and all
mutations involved in MWS and FCU are shown. Mutations in italics are those described in the present study. B, Alignment of the NACHT-
domain amino acid sequence from human cryopyrin, NALP2, and NALP3 (GenBank accession numbers AAG30289 and AF418985). Asterisks
(*) represent positions of mutations in the NACHT domain. Amimo acid homologies are represented by boldface characters.
same mutation, R260W, implying that MWS and FCU
are in fact the same syndrome, in which some clinical
signs, such as deafness, AA amyloidosis, and cold sen-
sitivity, are not always present. This strongly suggests
that mutations in CIAS1 do not account for a unique
genetic contribution and that unknown modifier genes
can influence the phenotype. This observation has al-
ready been made in patients with FMF who carry the
characteristic clinical signs and the same genotype but
who do not always develop AA amyloidosis. The pres-
ence of AA amyloidosis is highly influenced by the pres-
ence of polymorphisms in the SAA1 gene (Cazeneuve et
al. 2000). A similar observation in rheumatoid arthri-
tis has shown that polymorphisms in the SAA1 promot-
er may influence the development of AA amyloidosis
(Booth et al. 1998; Moriguchi et al. 1999, 2001). The
clinical signs of MWS and FCU seem to be more pro-
nounced than expected, since, in families 3 and 4, which
had recurrent febrile urticaria, the triggering effect of
cold and sensorineural deafness were absent. These two
families are similar to an Indian family described by
McDermott et al. (2000), which presented with incom-
plete clinical signs of MWS and FCU and showed linkage
to the same region. The spectrum of diseases associated
with CIAS1 mutations is thus not restricted to MWS
and FCU and will probably include some forms of fa-
milial inflammatory urticaria that, so far, have no genetic
explanation.
Several families in the present study displayed the
same mutation—families 1–4 (R260W) and families
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5–8 (T348M)—and therefore the question of a common
origin can be raised. We studied microsatellites and bial-
lelic polymorphisms in the patients carrying the same
mutation. No common haplotypes based on microsat-
ellites were found for these two mutations. The hap-
lotype analysis covers a 2.9-Mb region, including the
CIAS1 gene, which is probably too large to allow us to
observe a common origin, especially if the mutations
are ancient. On the basis of SNP analysis, we did not
observe significant haplotypes for the R260W mutation.
Unfortunately, it was not possible to obtain genomic
DNA from different patients of families 3 and 4. The
R260W mutation is carried in families who do not share
a common ethnic origin. Until now, MWS and FCU had
been reported only in northern-European populations;
however, family 4 is from Algeria, which enlarges the
ethnic spectrum. We therefore suspect that the R260W
mutation appears on different chromosomes. Among
families 5–8, which share the same common T348M
mutation, preliminary results of SNP study seem to in-
dicate that the T348M mutation appeared on different
chromosomes.
At this time, all mutations in both syndromes are mis-
sense mutations located in exon 3 of the CIAS1 gene
and mainly involve the NACHT domain (fig. 4). The
“NACHT” family acronym was recently used by Koonin
and Aravind (2001) and is based on the following protein
names: NAIP (neuronal apoptosis inhibitor protein),
CIIA (MHC class II transcription activator CIITA), HET-
E (bacterial nucleotide triphosphatase protein) and TP1
(telomerase-associated protein). The existence of this new
family was assessed with the identification of a new pro-
apoptotic protein—CARD4, which contains a nucleotide
triphosphatase protein—that has a highly significant se-
quence similarity to CIITA and that activates NF-kB. The
role of the NACHT domain is not actually known, but
mutations in genes encoding a NACHT domain have
recently been found to be involved in inflammatory dis-
eases such as Blau syndrome and Crohn disease (Hugot
et al. 2001; Miceli-Richard et al. 2001; Ogura et al.
2001). The highest degree of homology between NACHT
domains has been found between cryopyrin, NALP2, and
NALP3 (fig. 4). Mutations observed in cryopyrin are lo-
cated on amino acids conserved among these three pro-
teins. Of the 14 mutations responsible for MWS and
FCU, 12 described so far consist of the replacement of
either a cytosine by a thymine or a guanine by an adenine.
This suggests that exon 3 of CIAS1 contains several mu-
tational hotspots, and it supports the hypothesis that de-
amination of methylcytosines in CpG sites represents one
major mechanism underlying the occurrence of MWS
and FCU. This hypothesis could allow us to clarify several
points: (1) two de novo mutations were found in four
families (Hoffman et al. 2001a); (2) transmission of the
disease phenotype was associated with the T348M mu-
tation only over two generations; and (3) high mutability
of two codons was observed—codon 439, where two
different mutations, A439T and A439V, were found
(GCGrACG [present study] and GCGrGTG [Hoffman
et al. 2001a], respectively), and codon 260, where a
R260W mutation (CGGrTGG) and a frequent poly-
morphism (CGGrCGA) were observed.
Discovery of involvement of the CIAS1 gene in MWS
and in FCU confirms the genetic heterogeneity of dom-
inantly inherited forms of recurrent fevers. The clinical
spectrum of diseases associated with CIAS1 mutations
is not limited to MWS and FCU and includes another
form of familial urticaria, which does not meet the clin-
ical criteria for MWS and FCU. The new diagnostic test
will help in the clinical diagnosis and management of
the conditions in patients affected with inflammatory
recurrent syndromes, including those who belong to an
ethnic group known to be at risk for FMF.
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